Cytek Biosciences, Inc.

Cytek Biosciences, Inc. (CTKB) priced its initial public offering on Jul 23, 2021 at $17.00 per share, within its $16.00–$18.00 range, raising $247.6M, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $2.22B. Goldman Sachs was lead-left underwriter. Cooley advised the company and A&O Shearman advised the underwriters.

Cytek Biosciences, Inc. develops cell analysis tools for biomedical research and clinical applications. Its Aurora and Northern Lights systems are full spectrum flow cytometers that use multiple lasers to distinguish fluorescent tags on single cells.

Status

IPO

Ticker

CTKB

Exchange

Nasdaq Global Select

Priced

Jul 23, 2021

IPO price

$17.00

Price range

$16.00–$18.00

Raised

$247.6M

Market cap at IPO price

$2.22B

First filed

Jul 2, 2021

Underwriters

Goldman Sachs

Company counsel

Cooley

Underwriters' counsel

A&O Shearman

Sector

Industrials & materials

Country / state

CA

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.